Protective effects of anti-ricin A-chain RNA aptamer against ricin toxicity

World Journal of Gastroenterology

Volumn 14, Issue 41, 2008, Pages 6360-6365

  Fan, Shaoan ^a   Wu, Feng ^a   Martiniuk, Frank ^a   Hale, Martha L ^b   Ellington, Andrew D ^c   Tchou Wong, Kam Meng ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Luciferase assay; Ricin inhibitor; RNA aptamer

Indexed keywords

APTAMER; LUCIFERASE; MESSENGER RNA; RICIN A; RICIN A ANTIBODY; RICIN ANTIBODY; RNA ANTIBODY; UNCLASSIFIED DRUG; ANTIDOTE; PROTEIN SYNTHESIS INHIBITOR; RICIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG SYNTHESIS; INTOXICATION; NONHUMAN; PROMOTER REGION; PROTEIN SYNTHESIS INHIBITION; RETICULOCYTE; RNA TRANSLATION; ANIMAL; CHO CELL; CRICETULUS; DOSE RESPONSE; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; HAMSTER; KINETICS; METABOLISM; PROTEIN SYNTHESIS; REPORTER GENE;

ANIMALS; ANTIDOTES; APTAMERS, NUCLEOTIDE; CELL PROLIFERATION; CHO CELLS; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, REPORTER; KINETICS; LUCIFERASES; PROTEIN BIOSYNTHESIS; PROTEIN SYNTHESIS INHIBITORS; RICIN; TRANSFECTION;

EID: 63449117561     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.6360     Document Type: Article

References (20)

1. Audi J, Belson M, Patel M, Schier J, Osterloh J. Ricin poisoning: a comprehensive review. JAMA 2005; 294: 2342-2351
2. Yoder JM, Aslam RU, Mantis NJ. Evidence for widespread epithelial damage and coincident production of monocyte chemotactic protein 1 in a murine model of intestinal ricin intoxication. Infect Immun 2007; 75: 1745-1750
3. Korcheva V, Wong J, Corless C, Iordanov M, Magun B. Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome. Am J Pathol 2005; 166: 323-339
4. Olsnes S, Refsnes K, Pihl A. Mechanism of action of the toxic lectins abrin and ricin. Nature 1974; 249: 627-631
5. Stirpe F, Barbieri L. Ribosome-inactivating proteins up to date. FEBS Lett 1986; 195: 1-8
6. Lord JM, Roberts LM, Robertus JD. Ricin: structure, mode of action, and some current applications. FASEB J 1994; 8: 201-208
7. Lord JM, Deeks E, Marsden CJ, Moore K, Pateman C, Smith DC, Spooner RA, Watson P, Roberts LM. Retrograde transport of toxins across the endoplasmic reticulum membrane. Biochem Soc Trans 2003; 31: 1260-1262
8. Endo Y, Tsurugi K. The RNA N-glycosidase activity of ricin A-chain. The characteristics of the enzymatic activity of ricin A-chain with ribosomes and with rRNA. J Biol Chem 1988; 263: 8735-8739
9. Olsnes S, Pihl A. Different biological properties of the two constituent peptide chains of ricin, a toxic protein inhibiting protein synthesis. Biochemistry 1973; 12: 3121-3126
10. Wool IG, Gluck A, Endo Y. Ribotoxin recognition of ribosomal RNA and a proposal for the mechanism of translocation. Trends Biochem Sci 1992; 17: 266-269
11. Rainey GJ, Young JA. Antitoxins: novel strategies to target agents of bioterrorism. Nat Rev Microbiol 2004; 2: 721-726
12. Mantis NJ. Vaccines against the category B toxins: Staphylococcal enterotoxin B, epsilon toxin and ricin. Adv Drug Deliv Rev 2005; 57: 1424-1439
13. Hesselberth JR, Miller D, Robertus J, Ellington AD. In vitro selection of RNA molecules that inhibit the activity of ricin A-chain. J Biol Chem 2000; 275: 4937-4942
14. Zhao L, Haslam DB. A quantitative and highly sensitive luciferase-based assay for bacterial toxins that inhibit protein synthesis. J Med Microbiol 2005; 54: 1023-1030
15. Hale ML. Microtiter-based assay for evaluating the biological activity of ribosome-inactivating proteins. Pharmacol Toxicol 2001; 88: 255-260
16. Dertzbaugh MT, Rossi CA, Paddle BM, Hale M, Poretski M, Alderton MR. Monoclonal antibodies to ricin: in vitro inhibition of toxicity and utility as diagnostic reagents. Hybridoma (Larchmt) 2005; 24: 236-243
17. Pratt TS, Pincus SH, Hale ML, Moreira AL, Roy CJ, Tchou-Wong KM. Oropharyngeal aspiration of ricin as a lung challenge model for evaluation of the therapeutic index of antibodies against ricin A-chain for post-exposure treatment. Exp Lung Res 2007; 33: 459-481
18. Symensma TL, Giver L, Zapp M, Takle GB, Ellington AD. RNA aptamers selected to bind human immunodeficiency virus type 1 Rev in vitro are Rev responsive in vivo. J Virol 1996; 70: 179-187
19. Miller DJ, Ravikumar K, Shen H, Suh JK, Kerwin SM, Robertus JD. Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibition. J Med Chem 2002; 45: 90-98
20. de Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S. Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 1987; 7: 725-737